CAR20.19.22 T-cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAR20.19.22 T-cells, covering 2024-09-19 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: CAR20.19.22 T-cells in Relapsed, Refractory B-cell Malignancies [Phase 1]